FONAR Corp.

How big is FONAR Corp.?

As of Jun 18, FONAR Corp. has a market capitalization of 89.01 million, with net sales of 103.01 million and a net profit of 10.96 million reported over the latest four quarters. As of Jun 24, the company has shareholder's funds of 165.97 million and total assets of 214.25 million.

Market Cap: As of Jun 18, FONAR Corp. has a market capitalization of 89.01 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, FONAR Corp. reported net sales of 103.01 million and a net profit of 10.96 million.<BR><BR>Balance Sheet Snapshot: As of Jun 24, the company reported shareholder's funds of 165.97 million and total assets of 214.25 million.

What does FONAR Corp. do?

FONAR Corp. designs, manufactures, and services MRI scanners, operating as a micro-cap company with recent net sales of $27 million and a net profit of $3 million. It has a market cap of $89.01 million and key metrics include a P/E ratio of 8.00 and a return on equity of 6.38%.

Overview: <BR>FONAR Corp. is engaged in designing, manufacturing, selling, and servicing magnetic resonance imaging (MRI) scanners, operating within the Miscellaneous industry and classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 27 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 3 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 89.01 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 8.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.30 <BR>Return on Equity: 6.38% <BR>Price to Book: 0.52<BR><BR>Contact Details: <BR>Address: 110 Marcus Dr, MELVILLE NY: 11747-4228 <BR>Tel: 1 631 6942929 <BR>Website: http://www.fonar.com/

Should I buy, sell or hold FONAR Corp.?

Who are in the management team of FONAR Corp.?

As of March 2022, FONAR Corp.'s management team includes Dr. Raymond Damadian as Chairman, Principal Financial Officer, and Treasurer, with Mrs. Claudette Chan as Secretary and Director, alongside independent directors Mr. Ronald Lehman, Mr. Charles O'Data, and Mr. Richard Turk.

As of March 2022, the management team of FONAR Corp. includes Dr. Raymond Damadian, who serves as the Chairman of the Board, Principal Financial Officer, and Treasurer. Mrs. Claudette Chan is the Secretary and a Director. Additionally, the board features independent directors: Mr. Ronald Lehman, Mr. Charles O'Data, and Richard Turk.

Is FONAR Corp. technically bullish or bearish?

As of July 24, 2025, FONAR Corp. has shifted to a mildly bullish trend supported by the weekly MACD and moving averages, despite underperforming the S&P 500 with year-to-date returns of 2.44% compared to 12.22%.

As of 24 July 2025, the technical trend for FONAR Corp. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, supporting the positive trend, while the daily moving averages also indicate a mildly bullish stance. However, the monthly Bollinger Bands are bearish, and the KST shows a mixed signal with a bullish weekly but bearish monthly reading. The overall technical stance is mildly bullish, driven primarily by the weekly MACD and moving averages. <BR><BR>In terms of multi-period returns, FONAR has underperformed the S&P 500 year-to-date and over the past year, with returns of 2.44% and -10.86%, respectively, compared to the S&P 500's 12.22% and 17.14%. Over three years, FONAR shows a return of 8.84%, significantly lagging behind the S&P 500's 70.41%.

Is FONAR Corp. overvalued or undervalued?

As of October 17, 2025, FONAR Corp. is fairly valued with a P/E ratio of 8 and a Price to Book Value of 0.53, but has underperformed the S&P 500 with a 1Y return of -1.08%.

As of 17 October 2025, the valuation grade for FONAR Corp. has moved from attractive to fair, indicating a shift in its perceived value. Based on the current metrics, the company appears to be fairly valued. Key ratios include a P/E ratio of 8, a Price to Book Value of 0.53, and an EV to EBITDA of 2.31, which suggest that the stock is trading at a discount relative to its earnings and book value.<BR><BR>In comparison to peers, FONAR Corp. has a P/E ratio of 8.9956, while Longboard Pharmaceuticals, Inc. shows a significantly negative P/E of -27.0419, indicating that FONAR is in a better position relative to this peer. The return performance of FONAR Corp. has lagged behind the S&P 500, with a 1Y return of -1.08% compared to the S&P 500's 14.08%, reflecting challenges in the stock's performance over the past year.